Immune complexes inhibit apoptosis of chronic lymphocytic leukaemia B cells

R Gamberale1, J R Geffner, A Trevani

  • 1Laboratory of Immunology, Institute of Haematologic Research, National Academy of Medicine, Buenos Aires, Argentina.

Insights

Immune complexes (IC) prevent apoptosis in chronic lymphocytic leukemia (B-CLL) B cells by engaging accessory immune cells. This effect, partly mediated by IFN-gamma release, also increases HLA-DR expression on B-CLL cells.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Chronic lymphocytic leukemia (B-CLL) is a B-cell malignancy.
  • Understanding factors influencing B-CLL cell survival is crucial for treatment strategies.

Purpose of the Study:

  • To investigate the impact of immune complexes (IC) on the apoptosis of B-CLL cells.
  • To elucidate the mechanisms underlying IC-mediated modulation of B-CLL cell survival.

Main Methods:

  • Incubation of B-CLL cells with various forms of IC (pIC, E-IgG, aIgG).
  • Assessment of spontaneous and drug-induced apoptosis.
  • Depletion of accessory immune cells (T lymphocytes, monocytes, NK cells).
  • Use of neutralizing anti-IFNgamma monoclonal antibodies (MoAb).
  • Analysis of HLA-DR expression on B-CLL cells.

Main Results:

  • IC significantly inhibited spontaneous and chemotherapy-induced apoptosis of B-CLL cells.
  • The anti-apoptotic effect of IC was dependent on the presence of accessory leucocytes.
  • IFN-gamma released by non-malignant cells contributed to the IC-mediated inhibition of apoptosis.
  • IC treatment led to increased HLA-DR expression on B-CLL cells, indicating cellular activation.

Conclusions:

  • Immune complexes protect B-CLL cells from apoptosis through interactions with accessory immune cells.
  • IFN-gamma plays a partial role in mediating these protective effects.
  • IC-induced apoptosis inhibition is associated with B-CLL cell activation, evidenced by increased HLA-DR expression.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...